It’s a question posed in a The New York Times article last week that explored MRIs in sports medicine.
Are MRIs overused? It’s a question posed in a The New York Times article last week that explored MRIs in sports medicine.
“If you want an excuse to operate on a pitcher’s throwing shoulder, just get an MRI,” James Andrews, MD, a sports medicine orthopedist in Gulf Breeze, Fla., told the Times. He suspected that MRIs were overused, so he scanned 31 healthy athletes and found 90 percent had abnormal cartilage and 87 percent had abnormal rotator cuff tendons. Andrews and his sports medicine colleagues say that indeed the scan is overused and often not the oppropriate scan in sports injuries.
MRIs are sensitive but not very specific, as one doctor explained, so they can lead to misdiagnoses and unnecessary treatments in sports medicine. Yet, sports medicine patients often demand an MRI and physicians are reluctant not to order one, according to the Times.
Of course, MRIs can be extremely helpful in sports medicine, but must be considered alongside history and an exam to avoid overuse, according to one source.
What do you think? Is there a fine line between appropriate use and overuse? Are there other areas where MRIs are often ordered but might not be the right scan?
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.